OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PRICING FOR MULTI INDICATION MEDICINES: A DISCUSSION WITH ITALIAN EXPERTS
L. Pani, A. Cicchetti, A. De Luca, et al.
(2022), Iss. online first
Open Access | Times Cited: 5
L. Pani, A. Cicchetti, A. De Luca, et al.
(2022), Iss. online first
Open Access | Times Cited: 5
Showing 5 citing articles:
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
Rosanna Ruggiero, Nunzia Balzano, Maria Maddalena Nicoletti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 394-394
Open Access | Times Cited: 5
Rosanna Ruggiero, Nunzia Balzano, Maria Maddalena Nicoletti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 394-394
Open Access | Times Cited: 5
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Elvio Emanuele Rossini, Carlotta Galeone, Chiara Lucchetti, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 2, pp. 251-261
Open Access | Times Cited: 2
Elvio Emanuele Rossini, Carlotta Galeone, Chiara Lucchetti, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 2, pp. 251-261
Open Access | Times Cited: 2
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe
Claudio Jommi, Arianna Bertolani, Patrizio Armeni, et al.
Health Policy and Technology (2023) Vol. 12, Iss. 3, pp. 100771-100771
Open Access | Times Cited: 6
Claudio Jommi, Arianna Bertolani, Patrizio Armeni, et al.
Health Policy and Technology (2023) Vol. 12, Iss. 3, pp. 100771-100771
Open Access | Times Cited: 6
Not one, but many: developing a multi-indication pricing model for medicines in Belgium
Ingrid Maes, Eline de Kok, Pieter-Jan De Torck, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Ingrid Maes, Eline de Kok, Pieter-Jan De Torck, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Retinoprotective compounds, current efficacy, and future prospective
Rachele Marino, Rebecca M. Sappington, Marco Feligioni
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2619-2622
Open Access
Rachele Marino, Rebecca M. Sappington, Marco Feligioni
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2619-2622
Open Access
